ctrl K

Price Alert

NeuroSense Therapeutics L... (NRSN)

NASDAQ: NRSN · Real-Time Price · USD

1.25

0.02 (1.63%)

At close: Oct 03, 2025, 3:59 PM

1.25

0.00%

After-hours: Oct 03, 2025, 07:58 PM EDT

NeuroSense Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3.38M	2.64M	3.54M	11.06M
Short-Term Investments	n/a	n/a	3.55M	n/a
Long-Term Investments	23K	22K	n/a	n/a
Other Long-Term Assets	n/a	9K	23K	n/a
Receivables	164K	166K	131K	178K
Inventory	n/a	n/a	-3.68M	-178K
Other Current Assets	35K	40K	3.71M	217K
Total Current Assets	4.4M	2.92M	7.38M	11.41M
Property-Plant & Equipment	150K	238K	306K	19K
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	173K	269K	329K	19K
Total Assets	4.58M	3.18M	7.71M	11.43M
Account Payables	1.16M	1.46M	498K	39K
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	73K	69K	64K	n/a
Other Current Liabilities	188K	545K	349K	443K
Total Current Liabilities	1.99M	3.46M	1.73M	597K
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	1.41M	218K	1.83M
Total Long-Term Liabilities	n/a	1.59M	365K	1.83M
Total Liabilities	1.99M	4.94M	2.09M	2.42M
Total Debt	73K	142K	211K	1.83M
Book Value	2.58M	-1.77M	5.62M	9.01M
Book Value Per Share	0.14	-0.13	0.49	0.83
Common Stock	n/a	n/a	n/a	n/a
Retained Earnings	-36.66M	-26.12M	-20.79M	-8.45M
Comprehensive Income	n/a	24.36M	26.41M	n/a
Shareholders Equity	2.58M	-1.87M	5.62M	9.01M
Total Investments	23K	22K	3.55M	n/a